Medication Brand Name:

Gleevec

 
Active Ingredient:
imatinib mesylate
 
DIN(s) in Canada:
02253275, 02253283
 
francais
Manufacturer/Distributor:
Novartis Pharmaceuticals Canada Inc.
 
DrugCoverage Category:
Cancer
 
See Also:


Gleevec is an eligible benefit through most private insurance plans, provincial drug benefit programs / provincial cancer agencies and federal drug programs. See summary below. More detailed information (including reimbursement criteria, guidelines, claim forms) can be accessed by clicking HERE.
CML Alliance Program: 1 877 265 2554 and GIST Alliance 1 866 996-GIST or 1 866 996 4478 -specialized patient support programs designed to provide health information and financial support for patients who have been prescribed Gleevec .
Product Monograph
 
Coverage/Reimbursement by Private Insurance Plans in Canada
Gleevec is an eligible benefit through most private insurance plans. Some plans may require prior / special authorization before granting coverage. More detailed information (including reimbursement criteria, guidelines, claim forms) can be accessed by clicking HERE.
 
Coverage/Reimbursement by Canadian Provincial/Territorial Programs
Province Coverage Program / Eligibility Criteria
Alberta AB Covered Gleevec is covered according to eligibility criteria by the Alberta Cancer Board
British Columbia BC Covered Gleevec is covered according to eligibility criteria through the BC Cancer Agency
Manitoba MB Covered Gleevec is covered according to eligibility criteria under the Pharmacare Exception Drug Status Program
New Brunswick NB Covered Gleevec is covered according to eligibility criteria by New Brunswick Prescription Drug Program (NBPDP) under the Special Authorization process
Newfoundland & Labrador NL Covered Gleevec is covered according to eligibility criteria by the Newfoundland and Labrador Prescription Drug Program's (NLPDP) Special Authorization process
Northwest Territories NT Covered Gleevec is covered according to eligibility criteria by the Non-Insured Health Benefits (NIHB) Program
Nova Scotia NS Covered Gleevec is covered according to eligibility criteria by Nova Scotia Pharmacare through the Exception Drug Status (EDS) process
Nunavut NU Covered Gleevec is covered according to eligibility criteria by the Non-Insured Health Benefits (NIHB) Program
Ontario ON Covered Gleevec is covered by the Ontario Drug Benefit (ODB) Program (including clients of the Trillium Drug Program)
Prince Edward Island PE Covered Gleevec is covered by the PEI High Drug Cost Program
Quebec QC Covered Gleevec is covered according to eligibility criteria by the RAMQ and is on the liste de médicaments d'exception.
Saskatchewan SK Covered Gleevec is covered through the Saskatchewan Cancer Agency.
Yukon Territory YT Covered Gleevec is covered according to eligibility criteria by Yukon Pharmacare under Exception Drug Status.
 
Coverage/Reimbursement by Canadian Federal Plans
Plan Coverage Program / Eligibility Criteria
Public Services Health Care Plan Covered Gleevec is covered by the PSHCP
Non-Insured Health Benefits Program Covered Gleevec is covered according to eligibility criteria by the NIHB
Veterans Affairs Canada Covered Gleevec is covered by Veterans Affairs Canada through Special Authorization Formulary Benefits
Canadian Forces Health Services Covered Gleevec is covered according to eligibility criteria by the Canadian Forces Health Services
Interim Federal Health Plan Possible Coverage Gleevec may be covered by the IFHP
 
Health Canada Drug Product Database Listing
 
Terms of Use   |   Privacy Policy